FLXN Flexion Therapeutics Inc

Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including; anti-inflammatory and analgesic therapies.

$9.12  -0.02 (-0.22%)
As of 11/18/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2014
Outstanding shares:  50,321,366
Average volume:  2,466,234
Market cap:   $458,931,168
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    33938J106
ISIN:        US33938J1060
Valuation   (See tab for details)
PE ratio:   -4.56
PB ratio:   27.22
PS ratio:   4.57
Return on equity:   122.27%
Net income %:   -100.32%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy